DBV Technologies S.A. — Company profile
Healthcare · Biotechnology · France
Last price 9.49 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 561.70M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow’s milk protein allergy and eosinophilic esophagitis. The company’s earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.
Details
| Name | DBV Technologies S.A. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 170 |
| Founded | 2002 |
| Ceo | Daniel Tassé |
| Country | France |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US23306J3095 |
| Cusip | 23306J309 |
| Cik | 0001613780 |
| Sic | 2836 |
Key executives
| Name | Title |
|---|---|
| Daniel Tassé | Chief Executive Officer and Director |
| Virginie Simone Jeanine Verrechia Boucinha M.B.A. | Chief Financial Officer |
| Dr. Pharis Mohideen M.D. | Chief Medical Officer |
| Dr. Kevin P. Malobisky M.S., Ph.D., R.A.C. | Chief Operations Officer |
| Jonathan Neely | Vice President and Head of Investor Relations |
| Michele F. Robertson | Chief Legal Officer |
| James Briggs | Chief Human Resources Officer |
| Kevin Trapp | Chief Commercial Officer |
| Alan Kerr | Senior Vice President and Head of Global Regulatory Affairs |
| Pascal Wotling | Chief External Manufacturing and Supply Chain Officer |
Contact
| Address | BAtiment IRO, 107 Av. de la REpublique, Châtillon, 92320, France |
| Phone | 33 1 55 42 78 78 |
| Website | https://www.dbv-technologies.com |